Malignant complications of coeliac disease

被引:57
作者
Brousse, N
Meijer, JWR
机构
[1] Hop Necker Enfants Malad, Dept Pathol, Serv Anat & Cytol Pathol, F-75743 Paris, France
[2] Rijnstate Hosp, Dept Pathol, Arnhem, Netherlands
关键词
coeliac disease; malignant tumors; epithelial tumors; lymphoma; enteropathy associated T-cell lymphoma; ulcerative jejunitis; refractory coeliac disease;
D O I
10.1016/j.bpg.2005.02.002
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Patients with coeliac disease (CD), particularly those who are undiagnosed or do not adhere to a strict gluten free diet (GFD), are prone to develop complications. Malignant complications are the most serious and should be suspected when expected responses to GFD are not achieved or sustained. Lymphomas, mostly T-cell type, and other malignant tumours, particularly carcinoma of the small bowel, less frequently of stomach and oesophagus, are associated with CD. Loss of response to a gluten free diet (refractory coeliac disease) and ulcerative jejunitis are two recently described complications of CD that may progress to an Enteropathy-Associated T-cell Lymphoma (EATL). Coeliac disease-related lymphoma most often appears at extra-nodal sites, essentially the small bowel, although one have to realise that T-cell lymphomas arising in sites outside the small bowel could be related to coeliac disease. Workup of an EATL must include immunehistology and if necessary T-cell flow cytometry and T-cell rearrangement. Adequate imaging with CT and PET-scanning is mandatory.
引用
收藏
页码:401 / 412
页数:12
相关论文
共 47 条
[1]  
ALFSEN GC, 1989, HUM PATHOL, V20, P909
[2]  
[Anonymous], 1994, Extranodal Lymphomas
[3]   Cancer incidence in a population-based cohort of individuals hospitalized with Celiac disease or dermatitis herpetiformis [J].
Askling, J ;
Linet, M ;
Gridley, G ;
Halstensen, TS ;
Ekström, K ;
Ekbom, A .
GASTROENTEROLOGY, 2002, 123 (05) :1428-1435
[4]   Mucosal intra-epithelial lymphocytes in enteropathy-associated T-cell lymphoma, ulcerative jejunitis, and refractory celiac disease constitute a neoplastic population [J].
Bagdi, E ;
Diss, TC ;
Munson, P ;
Isaacson, PG .
BLOOD, 1999, 94 (01) :260-264
[5]  
BROUSSE N, 1989, LANCET, V2, P1107
[6]   Are complicated forms of celiac disease cryptic T-cell lymphomas? [J].
Carbonnel, F ;
Grollet-Bioul, L ;
Brouet, JC ;
Teilhac, MF ;
Cosnes, J ;
Angonin, R ;
Deschaseaux, M ;
Chatelet, FP ;
Gendre, JP ;
Sigaux, F .
BLOOD, 1998, 92 (10) :3879-3886
[7]   Risk of non-Hodgkin lymphoma in celiac disease [J].
Catassi, C ;
Fabiani, E ;
Corrao, G ;
Barbato, M ;
De Renzo, A ;
Carella, AM ;
Gabrielli, A ;
Leoni, P ;
Carroccio, A ;
Baldassarre, M ;
Bertolani, P ;
Caramaschi, P ;
Sozzi, M ;
Guariso, G ;
Volta, U ;
Corazza, GR .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (11) :1413-1419
[8]  
Catassi C, 2001, EUR J GASTROEN HEPAT, V13, P1123
[9]   Refractory sprue, coeliac disease, and enteropathy-associated T-cell lymphoma [J].
Cellier, C ;
Delabesse, E ;
Helmer, C ;
Patey, N ;
Matuchansky, C ;
Jabri, B ;
Macintyre, E ;
Cerf-Bensussan, N ;
Brousse, N .
LANCET, 2000, 356 (9225) :203-208
[10]   Coeliac disease: An update on facts and questions based on the 10th International Symposium on Coeliac Disease [J].
Cerf-Bensussan, N ;
Cellier, T ;
Heyman, M ;
Brousse, N ;
Schmitz, J .
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2003, 37 (04) :412-421